• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含胍基的脂肽纳米颗粒可实现骨骼肌内的高效基因编辑。

Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles.

机构信息

Wisconsin Institute for Discovery, University of Wisconsin-Madison, Madison, Wisconsin 53715, United States.

Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.

出版信息

ACS Appl Mater Interfaces. 2023 Mar 1;15(8):10464-10476. doi: 10.1021/acsami.2c21683. Epub 2023 Feb 17.

DOI:10.1021/acsami.2c21683
PMID:36800641
Abstract

Genome editing mediated by the CRISPR-Cas system holds great promise for the treatment of genetic diseases. However, safe and efficient in vivo delivery of CRISPR genome editing machinery remains a challenge. Here, we report a lipopeptide-based nanoparticle (LNP) that can efficiently deliver the CRISPR Cas9/sgRNA ribonucleoprotein (RNP) and enable efficient genome editing both and . An artificial lipopeptide, GD-LP, was constructed by linking a hydrophilic guanidinium-rich head to an oleic acid-based hydrophobic tail a disulfide bond. LNP formed by the self-assembly of GD-LP can easily form a complex with RNP with a loading content of up to 20 wt %. The resulting RNP-LNP nanocomplex led to 72.6% gene editing efficiency in GFP-HEK cells with negligible cytotoxicity. The LNP also showed significantly higher transfection efficiencies than Lipofectamine 2000 for the delivery of mRNA in NIH 3T3 and RAW 264.7 and the delivery of plasmid DNA in B78 cells. In vivo studies showed that intramuscular injection of the RNP-LNP nanocomplex in Ai14 mice induced efficient gene editing in muscular tissues. Moreover, the delivery of Cas9 RNP and donor DNA by LNP (., RNP/ssODN-LNP nanocomplex) restored dystrophin expression, reduced skeletal muscle fibrosis, and significantly improved muscle strength in a Duchenne muscular dystrophy (DMD) mouse model.

摘要

基于 CRISPR-Cas 系统的基因组编辑在治疗遗传疾病方面具有巨大的潜力。然而,安全有效地将 CRISPR 基因组编辑机制递送到体内仍然是一个挑战。在这里,我们报告了一种基于脂肽的纳米颗粒 (LNP),它可以有效地递送 CRISPR Cas9/sgRNA 核糖核蛋白 (RNP),并能够在体内和体外实现高效的基因组编辑。人工脂肽 GD-LP 是通过将亲水的胍基丰富的头部连接到基于油酸的疏水尾部 一个二硫键来构建的。由 GD-LP 自组装形成的 LNP 可以很容易地与 RNP 形成复合物,负载量高达 20wt%。所得的 RNP-LNP 纳米复合物在 GFP-HEK 细胞中导致 72.6%的基因编辑效率,几乎没有细胞毒性。与 Lipofectamine 2000 相比,LNP 还显示出更高的转染效率,用于在 NIH 3T3 和 RAW 264.7 中递送 mRNA 以及在 B78 细胞中递送质粒 DNA。体内研究表明,在 Ai14 小鼠中肌肉内注射 RNP-LNP 纳米复合物可诱导肌肉组织中有效的基因编辑。此外,通过 LNP 递送 Cas9 RNP 和供体 DNA(即,RNP/ssODN-LNP 纳米复合物)可恢复肌营养不良蛋白的表达,减少骨骼肌纤维化,并显著改善 Duchenne 肌营养不良症 (DMD) 小鼠模型中的肌肉力量。

相似文献

1
Guanidinium-Rich Lipopeptide-Based Nanoparticle Enables Efficient Gene Editing in Skeletal Muscles.富含胍基的脂肽纳米颗粒可实现骨骼肌内的高效基因编辑。
ACS Appl Mater Interfaces. 2023 Mar 1;15(8):10464-10476. doi: 10.1021/acsami.2c21683. Epub 2023 Feb 17.
2
Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.脂质纳米颗粒介导的 CRISPR-Cas9 RNP 与 mRNA/sgRNA 递送至体内外基因编辑的比较分析。
Eur J Pharm Biopharm. 2024 Mar;196:114207. doi: 10.1016/j.ejpb.2024.114207. Epub 2024 Feb 6.
3
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice.LNP 的低免疫原性使得 CRISPR-Cas9 mRNA 能够在小鼠的骨骼肌中进行重复给药。
Nat Commun. 2021 Dec 8;12(1):7101. doi: 10.1038/s41467-021-26714-w.
4
Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.理性设计的 Cas9 核糖核蛋白纳米颗粒递送来实现有效的基因编辑。
J Control Release. 2022 May;345:108-119. doi: 10.1016/j.jconrel.2022.02.035. Epub 2022 Mar 3.
5
LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.LNP 介导的 CRISPR RNP 递送至小鼠角膜进行广泛的体内基因组编辑。
J Control Release. 2022 Oct;350:401-413. doi: 10.1016/j.jconrel.2022.08.042. Epub 2022 Aug 27.
6
A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries.一种 pH 响应型硅基金属有机框架杂化纳米颗粒,用于递送亲水性药物、核酸和 CRISPR-Cas9 基因组编辑系统。
J Control Release. 2020 Aug 10;324:194-203. doi: 10.1016/j.jconrel.2020.04.052. Epub 2020 May 5.
7
Lipid nanoparticle-based ribonucleoprotein delivery for in vivo genome editing.基于脂质纳米颗粒的核糖核蛋白递送来进行体内基因组编辑。
J Control Release. 2023 Mar;355:406-416. doi: 10.1016/j.jconrel.2023.02.008. Epub 2023 Feb 10.
8
Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.利用基于生物矿化的spCas9变体纳米颗粒对杜氏肌营养不良症进行基因编辑。
Acta Biomater. 2022 Dec;154:597-607. doi: 10.1016/j.actbio.2022.10.015. Epub 2022 Oct 13.
9
Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 RNP.通过脂质纳米颗粒递送稳定的CRISPR-Cas9核糖核蛋白对肺和肝脏进行编辑。
bioRxiv. 2023 Nov 15:2023.11.15.566339. doi: 10.1101/2023.11.15.566339.
10
Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.通过超分子聚合物介导的 Cas9 核糖核蛋白递送来编辑突变 KRAS 基因组,用于结直肠癌治疗。
J Control Release. 2020 Jun 10;322:236-247. doi: 10.1016/j.jconrel.2020.03.015. Epub 2020 Mar 10.

引用本文的文献

1
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications.用于临床应用中CRISPR-Cas9递送的精准靶向纳米颗粒
Nanomaterials (Basel). 2025 Apr 2;15(7):540. doi: 10.3390/nano15070540.
2
Advanced delivery systems for gene editing: A comprehensive review from the GenE-HumDi COST Action Working Group.用于基因编辑的先进递送系统:来自GenE-HumDi成本行动工作组的全面综述
Mol Ther Nucleic Acids. 2025 Jan 17;36(1):102457. doi: 10.1016/j.omtn.2025.102457. eCollection 2025 Mar 11.
3
Efficacy of Chitosan-N-Arginine Chitosomes in mRNA Delivery and Cell Viability Enhancement.
壳聚糖-N-精氨酸壳聚糖体在mRNA递送及增强细胞活力方面的功效
ACS Appl Bio Mater. 2024 Dec 16;7(12):8261-8271. doi: 10.1021/acsabm.4c00983. Epub 2024 Nov 18.
4
Inhalable Dry Powders for Lung mRNA Delivery.可吸入干粉用于肺部 mRNA 递药。
Adv Healthc Mater. 2024 Nov;13(29):e2400509. doi: 10.1002/adhm.202400509. Epub 2024 Oct 1.
5
Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.探索非病毒方法将 CRISPR-Cas 核糖核蛋白递送至造血干细胞。
Stem Cell Res Ther. 2024 Jul 29;15(1):233. doi: 10.1186/s13287-024-03848-4.
6
Guanidinium-based Integrated Peptide Dendrimers: Pioneer Nanocarrier in Cancer Therapy.胍基整合型肽树状聚合物:癌症治疗中的先驱纳米载体。
Protein Pept Lett. 2024;31(4):261-274. doi: 10.2174/0109298665292042240325052536.
7
The Current Situation and Development Prospect of Whole-Genome Screening.全基因组筛查的现状与发展前景。
Int J Mol Sci. 2024 Jan 4;25(1):658. doi: 10.3390/ijms25010658.